JP2004510417A - プロモーター配列 - Google Patents

プロモーター配列 Download PDF

Info

Publication number
JP2004510417A
JP2004510417A JP2002530771A JP2002530771A JP2004510417A JP 2004510417 A JP2004510417 A JP 2004510417A JP 2002530771 A JP2002530771 A JP 2002530771A JP 2002530771 A JP2002530771 A JP 2002530771A JP 2004510417 A JP2004510417 A JP 2004510417A
Authority
JP
Japan
Prior art keywords
foxc2
nucleotide sequence
nucleic acid
enhancer
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002530771A
Other languages
English (en)
Japanese (ja)
Inventor
スヴェン・エネベック
カタリナ・クローク
レナ・ロンダール
ワイス・ダブリュー・ワッサーマン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Swedish Orphan Biovitrum AB
Original Assignee
Biovitrum AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0003435A external-priority patent/SE0003435D0/xx
Priority claimed from SE0004102A external-priority patent/SE0004102D0/xx
Application filed by Biovitrum AB filed Critical Biovitrum AB
Publication of JP2004510417A publication Critical patent/JP2004510417A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Seasonings (AREA)
JP2002530771A 2000-09-26 2001-09-26 プロモーター配列 Pending JP2004510417A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE0003435A SE0003435D0 (sv) 2000-09-26 2000-09-26 Promoter sequences
US23889700P 2000-10-10 2000-10-10
SE0004102A SE0004102D0 (sv) 2000-11-09 2000-11-09 Promoter sequences II
PCT/SE2001/002098 WO2002027008A1 (fr) 2000-09-26 2001-09-26 Sequences de promoteurs

Publications (1)

Publication Number Publication Date
JP2004510417A true JP2004510417A (ja) 2004-04-08

Family

ID=27354602

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002530771A Pending JP2004510417A (ja) 2000-09-26 2001-09-26 プロモーター配列

Country Status (5)

Country Link
EP (1) EP1320623A1 (fr)
JP (1) JP2004510417A (fr)
AU (1) AU2001292481A1 (fr)
CA (1) CA2421620A1 (fr)
WO (1) WO2002027008A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7217692B2 (en) * 2002-01-29 2007-05-15 Leangene Ab Complex of a human FOXC2 protein and a FOXC2-interacting protein
WO2005035793A2 (fr) * 2003-10-09 2005-04-21 Decode Genetics Ehf. Marqueurs et haplotypes de cckar associes a des etats d'excedent de poids
SE0400489D0 (sv) * 2004-02-27 2004-02-27 Biovitrum Ab Therapeutic proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701963D0 (sv) * 1997-05-26 1997-05-26 Pharmacia & Upjohn Ab Novel transcription factor
CA2400342A1 (fr) * 2000-02-18 2001-08-23 Biovitrum Ab Modele animal transgenique destine a l'expression du gene foxc2 pour traiter l'obesite

Also Published As

Publication number Publication date
AU2001292481A1 (en) 2002-04-08
WO2002027008A1 (fr) 2002-04-04
CA2421620A1 (fr) 2002-04-04
EP1320623A1 (fr) 2003-06-25

Similar Documents

Publication Publication Date Title
Martin et al. The gene for histone RNA hairpin binding protein is located on human chromosome 4 and encodes a novel type of RNA binding protein
Durand et al. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency
Anderson et al. Isolation of a gene encoding a functional zinc finger protein homologous to erythroid Krüppel-like factor: identification of a new multigene family
Schramm et al. Recruitment of RNA polymerase III to its target promoters
KR101902526B1 (ko) 특이적 프로모터의 작제 방법
Scohy et al. Identification of KLF13 and KLF14 (SP6), novel members of the SP/XKLF transcription factor family
WO2002097090A1 (fr) Genes presentant une expression specifique aux cellules es
Seroussi et al. Characterization of the human NIPSNAP1 gene from 22q12: a member of a novel gene family
King et al. Characterization of a human gene encoding nucleosomal binding protein NSBP1
Muckenthaler et al. Iron‐regulatory protein‐1 (IRP‐1) is highly conserved in two invertebrate species: Characterization of IRP‐1 homologues in Drosophila melanogaster and Caenorhabditis elegans
Pan et al. An intronic polyadenylation site in human and mouse CstF-77 genes suggests an evolutionarily conserved regulatory mechanism
Xing et al. Identification of a novel gene SRG4 expressed at specific stages of mouse spermatogenesis
CN108893539B (zh) 猪肉质性状相关的circRNA及其应用
Gou et al. Identification and functional analysis of a novel human KRAB/C2H2 zinc finger gene ZNF300
JP2002540782A (ja) ヒト間葉ＤＮＡｓと発現産物
JP2004510417A (ja) プロモーター配列
Smits et al. Molecular cloning and characterization of the mouse Ecm1 gene and its 5′ regulatory sequences
Kasper et al. Different structural organization of the encephalopsin gene in man and mouse
US20050244842A1 (en) Promoter sequences
US10711279B2 (en) Promoter sequences
Carlsson et al. Genomic structure of mouse SPI-C and genomic structure and expression pattern of human SPI-C
Yu et al. Comparative analysis of the pig BAC sequence involved in the regulation of myostatin gene
Agata et al. Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR
Ran et al. Characterization of a novel zinc finger gene with increased expression in nondividing normal human cells
Romanelli et al. Functional characterization of the ribonucleoprotein, PTB-binding 1/Raver1 promoter region

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20050526